Products

Kraton Kraton™MD SEBS MD6951 M

    • Product Name: Kraton Kraton™MD SEBS MD6951 M
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    VTB
    Specifications
    HS Code 551427
    Product Name Kraton Kraton™MD SEBS MD6951 M
    Polymer Type SEBS hydrogenated styrene-ethylene-butylene-styrene block copolymer
    Molecular Structure Linear triblock copolymer
    Styrene Content 20 wt%
    Rubber Content 80 wt%
    Physical Form Powder
    Color White
    Odor Slight
    Density 0.90 g/cm³
    Bulk Density 0.45 g/cm³
    Melt Flow Rate 5 g/10 min at 230°C/2.16 kg
    Shore A Hardness 68
    Tensile Strength 30 MPa
    Elongation At Break 700%
    300 Modulus 4 MPa

    As an accredited Kraton Kraton™MD SEBS MD6951 M factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in 25 kg moisture-resistant bags, palletized and shrink-wrapped for safe industrial storage and handling.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Kraton™ MD SEBS MD6951 M loaded in 25 kg bags, palletized, secured, and sealed for ocean freight.
    Shipping Kraton™ MD SEBS MD6951 M is a non-hazardous styrenic block copolymer supplied as pellets. It is not regulated for transport under DOT, IATA, or IMDG. Ship in sealed, labeled containers/packaging; protect from moisture, heat, and contamination. Standard industrial handling applies; no special hazard labels required.
    Storage Store Kraton™ MD SEBS MD6951 M in a cool, dry, well-ventilated area at ambient temperature, away from direct sunlight, heat, flames, ignition sources, and strong oxidizers. Keep containers tightly closed, labeled, and protected from moisture and contamination. Avoid prolonged high-temperature exposure, practice first-in/first-out stock rotation, and maintain good housekeeping.
    Shelf Life Shelf life is generally 24 months from manufacture when kept in original unopened packaging, dry, and protected from direct sunlight.
    Application of Kraton Kraton™MD SEBS MD6951 M

    Peristaltic Pump Tubing Under Occlusion Fatigue and Production-Scale Extrusion

    In peristaltic pump tubing lines, Kraton™ MD6951 M is extruded as a plasticizer-free alternative to PVC in roller-pump circuits where repeated radial compression and flexing govern service life. Compounds for this segment generally retain MD6951 M as the continuous elastomer phase; hardness adjustment is achieved with 5–20 wt% polypropylene having a melt flow rate of 10–25 g/10 min, not with low-molecular-weight ester plasticizers, to limit extractables in fluid-contact use. Tubing is processed on single-screw extruders with L/D 24:1–30:1, compression ratio 2.5:1–3.0:1, screw speed 30–80 rpm, and die land ratio 10:1–15:1. Melt temperature measured at the die exit should not exceed 220°C, while melt pressure is held below 20 MPa to avoid polymer degradation and gel formation. For a typical 3.2 mm OD × 1.6 mm ID extension-set tube, vacuum sizing followed by water-bath cooling at 15–25°C maintains outer-diameter tolerance within ±0.05 mm. Assembled tube sets are subjected to dynamic occlusion testing at 60 cycles/min for 72 h using a pump head calibrated to 1.0 N·m occlusion force, followed by particulate counting under USP <788>. Compliance for gravity-feed infusion tubing is assessed against ISO 8536-4, while biological evaluation for patient contact may include ISO 10993-4 hemolysis and ISO 10993-5 cytotoxicity. The finished product is used in IV extension sets, enteral feeding circuits, and peristaltic pump cassettes. The formulation is not intended for high-pressure vascular applications; prolonged exposure to lipid emulsions may swell the ethylene/butylene midblock and reduce fitting retention forces.

    The multilayer cast-film configuration places MD6951 M adjacent to a polyolefin core when a soft, clear sealing surface is required for flexible medical pouches. A three-layer cast film may use a 5–10 µm maleated polypropylene tie layer, a 15–40 µm SEBS sealing layer containing 0–10 wt% linear low-density polyethylene for seal-strength tuning, and a 60–120 µm homopolymer polypropylene core. Coextrusion is performed on three-extruder lines with screw L/D 28:1–32:1, die lip gap 0.8–1.2 mm, air gap 100–150 mm, quench roll temperature 15–30°C, and line speed 40–120 m/min. Seal initiation temperature measured per ASTM F88 shifts upward with increasing homopolymer content; a sealing window of 105–130°C at 0.3 MPa and 0.5 s dwell is common for structures with a 20–40 µm SEBS layer. Haze and clarity are monitored per ASTM D1003; elevated haze above 15% at film thickness typically indicates gel dispersion failure or excessive processing shear. Compliance is established under USP <661.1> for plastic packaging and USP <661.2> for plastic components, with container performance verified to ISO 15747 for intravenous solution containers. The finished constructions are applied as IV bag overwrap, secondary containment for blood-component freezing, and wound-fluid collection pouches. The SEBS layer is not a replacement for polyamide or EVOH oxygen-barrier layers; oxygen transmission must be controlled by a separate core layer when oxygen-sensitive formulations are stored.

    What Restricts Extractable Mass in Injection-Moulded Liquid Drug Closures?

    Liquid drug closures moulded from MD6951 M are gated to avoid high shear because shear-induced heating above 240°C can initiate oxidative gel formation in the ethylene/butylene midblock. Closures are moulded neat or with 10–30 wt% polypropylene to shift hardness from the base elastomer range into 70–85 Shore A when tested per ASTM D2240. Injection moulding is run on 100–250 t clamp machines with melt temperature 190–230°C, injection speed 30–80 mm/s, holding pressure 30–60 MPa, and mould temperature 25–45°C. Gate diameter is held between 0.8–1.5 mm; cold-runner or hot-runner systems are acceptable if runner scrap is kept clean and reprocessed no more than 20% by weight. Extractable mass is controlled by avoiding paraffinic process oils, metallic stearate additives, and sulfur-based stabilizers. Compliance is tested per ISO 8871-1 for elastomeric closures for aqueous parenteral preparations and per USP <381> for elastomeric closure function. Terminal sterilization is validated by gamma irradiation at 25–40 kGy under ISO 11137 dose mapping. Needle penetration force measured per ISO 8871-3 rises at hardness above 85 Shore A; this sets the upper stiffness boundary for pre-filled syringe tip caps and IV bag port closures. Moisture uptake is low, but pre-drying at 80°C for 2–4 h is recommended if resin has been stored at relative humidity above 60%. The resulting closures are deployed as vial seals, pre-filled syringe tip caps, and IV bag port closures where low leachable mass after autoclaving is required.

    Gamma irradiation at 25–50 kGy induces progressive crosslinking in the ethylene/butylene midblock rather than chain scission; the resulting compression-set shift must be tracked per ASTM D395 Method B at 70°C for 22 h. Respiratory interface components such as nasal pillow cushions, CPAP mask cushions, and nebulizer mouthpieces are injection moulded or blow moulded from MD6951 M compounds containing 80–100 wt% SEBS and 0–20 wt% polypropylene for stiffness adjustment. Injection moulding uses 80–150 t clamp force, melt temperature 195–220°C, mould temperature 30–50°C, and vent depth 0.02–0.03 mm to prevent gas burns. Mould release agents are omitted from skin-contact formulations because residual silicone or amide waxes can alter cytotoxicity and irritation outcomes. Cytotoxicity is evaluated per ISO 10993-5, sensitisation and irritation per ISO 10993-10, and skin irritation per ISO 10993-23. REACH Annex XVII restrictions on polycyclic aromatic hydrocarbons apply to the rubber phase. Surface hardening after repeated disinfection is a known limitation; prolonged contact with strong solvent-based disinfectants should be qualified on production parts. Hydrogen peroxide plasma re-sterilisation is preferred over autoclave cycling when repeated reprocessing is expected. Published grade-specific data for the effect of repeated hydrogen peroxide plasma exposure on MD6951 M is limited; validation on actual moulded cushions is required.

    Overmoulding Without Primer on PP Substrates Under Adhesion Gradient Limits

    Overmoulding MD6951 M onto polypropylene substrates requires substrate surface temperature above the onset of PP recrystallization to promote interfacial interdiffusion. A substrate preheat of 80–120°C measured by infrared pyrometer is applied before the second shot. The first-shot PP component is transferred with surface temperature not below 80°C; lower temperatures cause cohesive peeling at the overmould boundary. The second shot uses melt temperature 210–230°C and holding pressure 25–45 MPa. Core cooling imbalance from thick SEBS cushions over thin PP ribs leads to sink marks; reducing core temperature differential to 10–20°C lowers cycle time by 8–15%. Adding 5–10 wt% polypropylene to the overmould compound narrows the interfacial viscosity mismatch and improves primerless adhesion. Peel resistance may be assessed per ASTM D903; cohesive failure within the SEBS layer is the acceptance target, not adhesive failure at the interface. Cytotoxicity is tested per ISO 10993-5, and patient-contact components are qualified under USP Class VI protocols. The finished assemblies are used in handheld diagnostic housings, insulin pen overmoulds, and surgical instrument grips. Published data for primerless adhesion on PP moulded below 60°C is limited; plasma or corona surface activation may be required when substrate temperature cannot be maintained.

    When SEBS Replaces Thermoset Rubber in Lyophilisation Stoppers

    When SEBS replaces bromobutyl rubber in lyophilisation stoppers, the closure must remain seated in the partially inserted position during freeze-drying and later seal without fragmentation. MD6951 M is injection moulded in multi-cavity tools with short runners to maintain cavity-to-cavity weight variation below 1.5%. Hardness is adjusted with 10–25 wt% polypropylene to achieve stopper functionality; if lower durometer is required, medical white oil at 5–15 wt% may be added with mandatory extractables screening per USP <1663>. Moulded stoppers are washed in water-for-injection at 70–80°C and siliconized at 0.1–0.5 mg/cm² of medical silicone oil to control machinability without excessive free silicone. Functional requirements are tested per ISO 8871-5, while general requirements follow ISO 8871-1. Container closure integrity is verified under USP <1207> using vacuum decay or tracer-gas methods. Terminal steam sterilisation at 121°C for 30 min or gamma irradiation at 25–40 kGy is applicable; steam resistance should be confirmed because saturated steam at 121°C can increase surface tack in some SEBS formulations. The finished products are deployed as 20 mm lyophilisation stoppers, IV container caps, and dental cartridge plungers. Moisture uptake is lower than thermoset rubber, but residual moisture after freeze-drying must be controlled below 1% for moisture-sensitive APIs; gravimetric sorption at 25°C/60% RH for SEBS shows limited mass gain, though grade-specific data for MD6951 M should be generated for the final stopper geometry.

    Diagnostic cartridge gaskets require flatness and low compression set after dry-heat aging at 60°C for 72 h. MD6951 M is moulded as annular gaskets with thickness 0.3–1.2 mm, using valve-gated hot runner systems; gate vestige must not exceed 0.05 mm to avoid interference with microfluidic channel sealing. Compounds use neat MD6951 M or 3–8 wt% polypropylene for dimensional control; external lubricants are omitted because organic residues alter capillary wetting and fluorescence background. Melt temperature is held at 190–215°C, mould temperature at 25–40°C, and holding time is extended until gate freeze is confirmed by cavity pressure sensors. Cytotoxicity is tested per ISO 10993-5, and manufacturing quality is controlled under ISO 13485. Sealing performance is evaluated by air leak-down at 34.5 kPa for 30 s; no single ISO standard governs microfluidic gasket leak rate, so acceptance limits are derived from device-specific risk analysis. The finished parts are used as PCR cartridge seals, lateral flow cassette gaskets, and microfluidic chip interconnects. Published data for this specific configuration is limited; prototype validation on production-scale injection tools is required before design freeze.

    Comparative Processing Windows by Downstream Operation
    OperationMelt temperatureTool/roll temperatureKey control metricReference method
    Single-screw tubing extrusion190–220°C15–25°C water bathOD tolerance ±0.05 mmISO 8536-4
    Injection-moulded liquid drug closures190–230°C25–45°CShore A 70–85ASTM D2240
    Two-shot PP overmould210–230°CPP substrate 80–120°CCohesive peel failureASTM D903
    Valve-gated microfluidic gasket moulding190–215°C25–40°CGate vestige <0.05 mmISO 13485
    Compliance Matrix for Medical and Pharmaceutical Applications
    Component classPrimary standardTest conditionControlled attribute
    IV extension and peristaltic pump tubingUSP <788>After 72 h dynamic occlusionParticulate load
    Multilayer film for IV overwrapUSP <661.1>/<661.2>Phosphate buffer, water, alcohol extractionNon-volatile residue, heavy metals
    Elastomeric closures for aqueous parenteralsISO 8871-1Autoclave 121°C, 30 minHardness, penetrability, fragmentation
    Respiratory cushions and nasal pillowsISO 10993-5L929 agar overlay or extractionCytotoxicity score
    Device overmouldsUSP Class VISystemic injection, intracutaneous, implantationBiological reactivity
    Lyophilisation stoppersUSP <1207>Vacuum decay after pilot-scale cappingContainer closure integrity
    Free Quote

    Competitive Kraton Kraton™MD SEBS MD6951 M prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Kraton™ MD6951 M is a linear styrene-ethylene/butylene-styrene block copolymer in which the bound styrene content is 42% by weight. The elastomeric midblock is saturated ethylene/butylene, while the hard domains are glassy polystyrene; on cooling from melt processing, the polystyrene domains phase-separate into physical cross-links and form a network without vulcanization. The saturated midblock removes the main-chain double bonds present in styrene-butadiene-styrene analogues and is the primary reason for improved oxidative stability in this SEBS class. Supplier-published typical properties for the neat resin list a specific gravity of 0.91 (ASTM D792), hardness of 71 Shore A (ASTM D2240), tensile strength at break of approximately 33 MPa (ASTM D638), and elongation at break of approximately 880% (ASTM D638). The grade belongs to the MD series, which Kraton positions for medical and regulated applications; however, the raw resin itself is not a finished medical device and regulatory conformance must be established on the final compounded article through lot-specific certificates and biological testing. Melt processing is possible on conventional single-screw extruders, twin-screw compounding lines, and injection molding machines configured for polyolefin-grade thermoplastic elastomers.

    What Distinguishes MD6951 M from Lower-Styrene SEBS and Thermoplastic Polyurethanes?

    Compared with a 30% styrene SEBS representative such as Kraton G1652, the 42% styrene fraction of MD6951 M increases the volume fraction of glassy endblock domains. This raises the published 100% tensile modulus to approximately 2.8 MPa and the 300% modulus to approximately 4.4 MPa (ASTM D638). The penalty is a reduction in low-strain elastomeric recovery and a higher magnitude of stress relaxation at fixed extension because the relaxation spectrum is modified by the additional glassy phase. Against thermoplastic polyurethane, MD6951 M has a specific gravity of 0.91 instead of the 1.10–1.25 range typical for polyester or polyether TPU, and it does not require the aggressive drying that moisture-sensitive TPU requires. But the ultimate tensile strength of MD6951 M, approximately 33 MPa, is below the 40–70 MPa range frequently reported for engineering TPU grades; similarly, abrasion resistance and tear strength are lower. In comparison with a random polypropylene copolymer, MD6951 M provides much lower flexural modulus and superior low-temperature ductility; the ethylene/butylene segment retains elastomeric response well below −40 °C, whereas polypropylene homopolymer can exhibit brittle failure near 0 °C depending on molecular weight and cooling history. The glassy polystyrene domains, however, soften near 90–100 °C, and this limits continuous load-bearing service to temperatures below the glass transition of the endblock phase.

    Mechanical, Physical, and Rheological Property Ranges

    Published data for MD6951 M are generated on plaques conditioned at 23 ± 2 °C and 50 ± 10% relative humidity. The following table consolidates typical values from supplier literature and does not represent a lot-specific certificate of analysis.

    PropertyTest methodTypical published rangeUnit
    Specific gravityASTM D7920.90–0.92—
    HardnessASTM D224068–75Shore A
    Tensile strength at breakASTM D63830–35MPa
    Elongation at breakASTM D638800–900%
    100% tensile modulusASTM D6382.4–3.2MPa
    300% tensile modulusASTM D6383.9–4.8MPa
    Melt mass-flow rateASTM D1238, 230 °C/5.0 kg3–5g/10 min

    The mechanical response of MD6951 M is controlled by the microphase-separated morphology. The polystyrene endblock volume fraction of 0.38–0.42 is sufficient to form discontinuous spherical or short cylindrical domains in the ethylene/butylene matrix, depending on annealing conditions. Dynamic mechanical thermal analysis of similar high-styrene SEBS materials shows a glass transition of the ethylene/butylene phase near −55 °C and an endblock glass transition near 90–100 °C. The plateau modulus between these transitions is a function of the styrene content and domain morphology; the 42% styrene grade therefore has a higher plateau modulus than a 30% styrene SEBS. Tensile set after cyclic loading increases when the material is strained into the strain-softening region beyond the yield point of the glassy polystyrene domains. In injection moulded components, shear-induced orientation can produce anisotropic shrinkage and anisotropic mechanical response; moulded plaques should be conditioned and tested parallel and perpendicular to flow using ASTM D638 or ISO 527. The supplier-published value of tensile strength 33 MPa is a guide; moulded parts with knit lines or high residual orientation may exhibit lower values. Published DMTA data specific to MD6951 M are limited, so comparative measurements are taken on the actual formulation under ISO 6721-1.

    Chemical exposure data for MD6951 M follow general SEBS behaviour. The saturated ethylene/butylene midblock gives better resistance to oxidative aging and weather ageing than SBS, but the material is not recommended for continuous contact with aromatic hydrocarbons, chlorinated solvents, ketones, or strong acids because those fluids solvate the polystyrene domains or degrade the midblock. In applications requiring light contact with aliphatic hydrocarbons, dilute aqueous acids, and bases, the material is generally more dimensionally stable than polybutadiene-based SBS; however, published data for MD6951 M in specific solvent systems are limited, so immersion testing should follow ISO 1817 and ASTM D471 on the finished compound. In medical cleaning and repeated sterilization, lipid emulsions and alcohol-based disinfectants can extract low-molecular-weight additives and stress-crack the styrenic phase if the part is under strain; therefore the additive package and moulded-in stress must be evaluated rather than assuming resistance from the base polymer alone.

    When Low Extractables and Biological Reactivity Requirements Govern Material Selection

    MD6951 M is commonly specified for tubing, drip chambers, medicinal film, syringe plungers, and other device components where softness, clarity, and regulatory compatibility are required. The raw grade is not, by itself, a medical device; the finished article is qualified under ISO 10993-5 for cytotoxicity and, where contact is longer or internal, under USP <88> Class VI biological reactivity protocols. In food-contact packaging, formulations based on styrene block copolymers can be considered under 21 CFR 177.1810 when the finished article meets the end-use limitations of the regulation. To preserve low extractables, converters select stabilizer packages with low migration potential and avoid low-molecular-weight lubricants unless they are shown to remain within the extraction limits of the relevant monograph. Gamma sterilization at 25–50 kGy is commonly applied to SEBS-based medical devices; the saturated midblock is significantly less prone to radiation-induced chain scission than butadiene-based styrenic block copolymers. The specific colour shift after gamma irradiation is formulation-dependent and must be measured on the finished device material according to the device qualification plan.

    FrameworkStandard or clauseFunction in material qualification
    US PharmacopeiaUSP <88> Class VIIn vivo biological reactivity for elastomeric closures, tubing, and implant-test articles
    ISO 10993ISO 10993-5, ISO 10993-12Cytotoxicity and sample preparation for extractable testing
    FDA21 CFR 177.1810Styrene block copolymers for food-contact articles, with end-testing requirements
    ASTMASTM D638, ASTM D2240, ASTM D792, ASTM D1238Physical and rheological testing of plaques and pellets
    European UnionREACH 1907/2006/ECRegistration, SVHC disclosure, and communication obligations
    European UnionRoHS 2011/65/EUHeavy metal and brominated flame retardant limits for electrical/electronic end-uses

    On a 25:1 L/D single-screw extruder equipped with a barrier screw and strand pelletizing head, MD6951 M is typically run with barrel setpoints of 150–170 °C at the feed section, 170–190 °C in compression, 190–210 °C in metering, and 210–230 °C at the die. The melt temperature measured with an immersion thermocouple should be maintained below 230 °C. Above 240 °C, extended residence time produces yellowing, gel particles, and a downward drift in melt viscosity, even though the midblock is saturated; the degradation is primarily in the styrenic domains and the antioxidant package. MD6951 M is not hygroscopic, but surface moisture on pellets stored at relative humidity greater than 60% can create splay during extrusion. Pellets are therefore pre-dried at 65–75 °C for 2–4 h when condensation is observed. For injection molding, general-purpose polyolefin screws with 20:1 to 24:1 L/D and compression ratio of 2.5:1 to 3.0:1 are accepted; back pressure of 0.5–1.0 MPa and injection speeds of 30–80 mm/s are typical for thin-wall medical parts, but published data for specific mould geometries using MD6951 M are limited and melt temperature at the nozzle should be directly measured.

    Thin-walled tubing extruded from MD6951 M is often designed with an inner diameter tolerance of ±0.05 mm and wall thickness below 0.8 mm. The extrusion line uses a vacuum sizing tank, a puller, and an on-line diameter gauge. Surface roughness is controlled by keeping melt temperature at the die below 220 °C and by avoiding moisture condensation. Coextruded structures with polyethylene or polypropylene can improve clamp resistance and reduce tack in automated assembly. Film formulations containing MD6951 M are used in medical pouches and as monolayer or coextruded sealing layers; the sealing window is typically above 100 °C because the styrenic domains must soften sufficiently for heat seal formation. Specific seal strength is influenced by dwell time, pressure, and surface contamination; standard test methods include ASTM F88 for seal strength and ASTM F1929 for dye penetration. Published seal-strength data for MD6951 M in these structures are limited and should be generated on the commercial line.

    The Saturated Midblock Limits Oxidation but Polystyrene Domains Limit Upper Service Temperature

    In high-shear twin-screw compounding on a 40:1 L/D co-rotating extruder, viscous dissipation can raise the melt temperature above the barrel setpoint. Because the 42% styrene content increases viscosity relative to 30% styrene SEBS, the maximum screw speed before the melt exceeds 230 °C is lower under identical barrel settings. Screw configurations with short kneading blocks and forward conveying elements of pitch equal to the screw diameter are used to narrow the residence time distribution. Oil extension, if required, is introduced downstream because early injection leads to feed slippage and unstable throughput. In coextruded medical film with polypropylene, the higher styrene content increases the refractive index difference between the SEBS and the polypropylene phase; haze levels are therefore checked on the actual cast film structure using ASTM D1003, and published comparative haze data for MD6951 M are limited. The grade is not suitable for continuously load-bearing service above the styrenic domain glass transition region of 90–100 °C. During autoclave sterilization at 121 °C, parts should not be clamped or under stress because the polystyrene domains soften; the material should be re-evaluated for dimensional recovery before returning to load-bearing service. Peristaltic pump tubing made from MD6951 M is evaluated for tension set under ISO 6943 or ASTM D412; the 42% styrene level generally increases tension set relative to low-styrene SEBS, so dynamic applications should be tested at the specific strain and temperature.

    Top